"10.1371_journal.pone.0118881","plos one","2015-03-20T00:00:00Z","Kelly L Warfield; John M Dye; Jay B Wells; Robert C Unfer; Frederick W Holtsberg; Sergey Shulenin; Hong Vu; Dana L Swenson; Sina Bavari; M Javad Aman","Integrated Biotherapeutics, Inc., Gaithersburg, Maryland, United States of America; United States Army Medical Research Institute of Infectious Diseases, Fort Detrick, Maryland, United States of America","Conceived and designed the experiments: KLW JMD RCU FWH DLS SB MJA. Performed the experiments: KLW JMD JBW RCU SSS HV DLS. Analyzed the data: KLW JMD JBW RCU FWH SSS HV DLS MJA. Contributed reagents/materials/analysis tools: KLW JMD SB MJA. Wrote the paper: KLW JMD RCU FWH MJA.","We have the following interests. Kelly L. Warfield, Dana L. Swenson, Sina Bavari and M. Javid Aman are authors on US patent 7,682,618; Generation of virus-like particles and use as panfilovirus vaccine that is owned by the US Army Medical Research and Material Command. IBT is pursuing the development of filovirus VLP vaccine as a product. Kelly L. Warfield, Robert C. Unfer, Frederick W. Holtsberg, Sergey Shulenin, Hong Vu, and M. Javad Aman were employed by Integrated Biotherapeutics, Inc. at the time of the study. There are no further patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors and agree that PLOS One can change the online submission form on our behalf. After a review of the patent application history, it appears that other applications related to this work by the authors of this manuscript have been abandoned by the U.S. Army, as such we have removed the and other patents pending","2015","03","Kelly L Warfield","KLW",10,TRUE,7,7,9,5,TRUE,TRUE,FALSE,0,NA,FALSE
